Home › Meningioma › Massachusetts
Meningioma clinical trials in Massachusetts
6 studies for Meningioma are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Dana-Farber/Harvard Cancer Center, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 2, 2026 · NCT04374305A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
- Mass General, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.